Skip to main content
Signal8

SIDRANSKY DAVID

SEC insider (Form 3/4/5 filer). CIK 0001277161. Director at ASCENTAGE PHARMA GROUP INTERNATIONAL (AAPG) and 2 other issuers. 2 reported Form 4/5 transactions since Sep 2024; latest on Nov 5, 2025. Located in HACKENSACK, NJ.

Companies SIDRANSKY DAVID has filed insider reports for

  • ASCENTAGE PHARMA GROUP INTERNATIONAL (AAPG): Director
  • Galmed Pharmaceuticals Ltd. (GLMD): Director
  • CHAMPIONS ONCOLOGY, INC. (CSBR): Director
SIDRANSKY DAVID profile photo

SIDRANSKY DAVID

CIK: 0001277161

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)2 (100.0%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (3)

ASCENTAGE PHARMA GROUP INTERNATIONAL logo
AAPG

ASCENTAGE PHARMA GROUP INTERNATIONAL

Director
Galmed Pharmaceuticals Ltd. logo
GLMD

Galmed Pharmaceuticals Ltd.

Director
CHAMPIONS ONCOLOGY, INC. logo
CSBR

CHAMPIONS ONCOLOGY, INC.

Director

Discretionary Trading P&L

Holdings

Transaction History (2 total)

  • CHAMPIONS ONCOLOGY, INC. logo
    CSBR

    CHAMPIONS ONCOLOGY, INC.

    Nov 5, 2025
    Award

    Option to purchase Common Stock

    Direct
    21.2K shares at avg. $6.80-
  • CHAMPIONS ONCOLOGY, INC. logo
    CSBR

    CHAMPIONS ONCOLOGY, INC.

    Nov 12, 2024
    Award

    Option to purchase Common Stock

    Direct
    21.9K shares at avg. $4.64-

1-2 of 2